About Us

Accreditation History

Accredited by the American Society of Health-System Pharmacists

The PGY-1 Pharmacy Residency Program conducted by Riverside University Health System is accredited by the American Society of Health-System Pharmacists (ASHP).

RUHS PGY-1 Pharmacy Residency Program acquired ASHP Accreditation Candidate Status during the inaugural class (2016-2017). Subsequently, our program received ASHP Accreditation after the accreditation survey that took place in the spring of 2017.

Curriculum

Core Experiences

  • Acute Care Medicine (5 weeks)
  • Ambulatory Care (5 weeks)
  • Clinical Staffing (longitudinal)
  • Critical Care – Medical ICU (6 weeks)
  • Health Inequities & Structural Competency (longitudinal seminar)
  • Infectious Diseases (4 weeks)
  • Orientation (2 weeks)
  • Pharmacy Operations (longitudinal)
  • Practice Management (longitudinal)
  • Psychiatric Pharmacy (6 weeks)
  • Research Project (2 weeks plus longitudinal)

Elective Experiences (Three Elective Blocks)

  • Advanced Ambulatory Care & Administration
  • Cardiology
  • Critical Care II – Surgical ICU
  • Developmental Disabilities Clinic
  • Emergency Medicine
  • Hematology & Oncology (Infusion Center)
  • Informatics & Technology
  • Pediatrics
  • Pharmacy Administration
  • Extension of a Required Learning Experience

Elective Teaching Certificate (Longitudinal)

PGY1 Pharmacy Residency Preceptors

View preceptors by practice area

Administration

  • Davalyn Tidwell, PharmD, BCPS, DPLA

    Pharmacy School: University of Southern California

    PGY1: University of Southern California

  • Linda Tran, PharmD

    Pharmacy School: Western University of Health Sciences

  • Maggie Ton, PharmD, APh, SIDP, CMSO

    Pharmacy School: Oregon State University

  • Mark Tang, PharmD

    Pharmacy School: Western University of Health Sciences

  • Melissa Cloyd, PharmD, BCPS, BCPP, BCGP, DPLA

    Pharmacy School: University of the Pacific

    PGY1: Veteran Affairs New York Harbor

    PGY2: Psychiatric Pharmacy – Veteran Affairs San Diego

  • Sheri Emmons, PharmD

    Pharmacy School: University of Southern California

Ambulatory Care

  • Alexa Tuico, PharmD, BCACP

    Pharmacy School: Chapman University

    PGY1: Desert Hospital Outpatient Pharmacy Ambulatory Health

  • Fang-Tzu Hamade, PharmD, BCACP

    Pharmacy School: Ferris State University

    PGY1: Meijer Pharmacy, Ferris State University, and Pfizer

  • Hannah Noh, PharmD, BCACP

    Pharmacy School: Notre Dame of Maryland University

    PGY1: Virginia Garcia Memorial Health Center

    PGY2: Ambulatory Care – Kaiser Permanente Colorado

  • Hilary Lim, PharmD, APh

    Pharmacy School: University of the Pacific

    PGY1: Veteran Affairs Loma Linda

  • Jaye Kim, PharmD, BCACP

    Pharmacy School: University of California, San Diego

    PGY1: Riverside University Health System

  • Oscar Gallegos, PharmD, BCACP

    Pharmacy School: University of Southern California

    PGY1: University of Southern California

  • Quyen Phan, PharmD, BCACP

    Pharmacy School: Western University of Health Sciences

    PGY1: Kaiser Permanente Vallejo

Cardiology

  • Tong Young Huang, PharmD, BCCP

    Pharmacy School: University of Colorado

    PGY1: Riverside University Health System

    PGY2: Cardiology – University of Massachusetts

Critical Care

  • Anh Nguyen, PharmD, BCCCP, BCPS

    Pharmacy School: University of Southern California

  • Jeremy Price, PharmD, BCCCP

    Pharmacy School: University of Iowa

    PGY1: Riverside University Health System

Emergency Medicine

  • Anna Burley, PharmD

    Pharmacy School: University of Michigan

    PGY1: UCI Health – Fountain Valley

    PGY2: Critical Care – Pomona Valley Hospital

  • Cedric White, PharmD

    Pharmacy School: University of Connecticut

    PGY1: Massachusetts General Hospital

    PGY2: Emergency Medicine – Boston Medical Center

  • Grace Shinn, PharmD, BCCCP

    Pharmacy School: Loma Linda University

    PGY1: NewYork-Presbyterian Hospital

    PGY2: Critical Care – NewYork-Presbyterian Hospital

  • Karolina Kapustova, PharmD, BCEMP

    Pharmacy School: University of Southern California

    PGY1: Riverside University Health System

    PGY2: Emergency Medicine – University Health

  • Mia Choi, PharmD, BCEMP

    Pharmacy School: Loma Linda University

    PGY1: Massachusetts General Hospital

    PGY2: Emergency Medicine – Jackson Memorial Hospital

Hematology and Oncology

  • Bode Olatunji, PharmD

    Pharmacy School: Howard University

  • Eric Yang, PharmD

    Pharmacy School: University of Colorado

    PGY1: Riverside University Health System

Infectious Diseases

  • Joanne Chiu, PharmD, BCIDP

    Pharmacy School: University of California, San Diego

    PGY1: Scripps Mercy Hospital

    PGY2: Infectious Diseases – University of Southern California

  • Nikki Mulligan, PharmD, BCIDP

    Pharmacy School: University of California, San Diego

    PGY1: Oregon Health & Science University

    PGY2: Infectious Diseases – Veteran Affairs San Diego

Informatics

  • Byung Uk Im, PharmD

    Pharmacy School: Loma Linda University

  • Justin Chang, PharmD

    Pharmacy School: University of the Pacific

    PGY1: Riverside University Health System

Internal Medicine and Surgery

  • Anhdiem Le, PharmD, BCPS, BCCCP, BCNSP

    Pharmacy School: Western University of Health Sciences

  • Karen Nguyen, PharmD, BCPS, BCCCP, BCPPS

    Pharmacy School: Loma Linda University

  • Man Nguyen, PharmD, BCCCP, BCPS

    Pharmacy School: Loma Linda University

    PGY1: UCI Health – Fountain Valley

  • Megan Lai, PharmD

    Pharmacy School: Midwestern University – Glendale

    PGY1: Saint Joseph's Hospital and Medical Center

  • Monica Hong, PharmD

    Pharmacy School: Loma Linda University

    PGY1: University Medical Center of Southern Nevada

  • Thomas Lee, PharmD, BCPS

    Pharmacy School: Keck Graduate Institute

    PGY1: Riverside University Health System

  • Vinh Bui, PharmD, BCPS

    Pharmacy School: Loma Linda University

Pediatrics

  • Elhaam Mesghali, PharmD

    Pharmacy School: University of the Pacific

    PGY1: Loma Linda University

    PGY2: Pediatrics – Loma Linda University

  • Nerissa Alday, PharmD, BCPS, BCPPS

    Pharmacy School: University of Florida

    PGY1: The Ohio State University

    PGY2: Pediatrics – Nationwide Children's Hospital

Pharmacy Operations

  • Brandon Fong, PharmD

    Pharmacy School: University of the Pacific

  • Timothy Kim, PharmD

    Pharmacy School: Loma Linda University

Psychiatric Pharmacy

  • Andy Williams, PharmD, BCPP, FAAPP

    Pharmacy School: University of Southern California

    PGY1: University of Southern California

    PGY2: Psychiatric Pharmacy – University of Southern California

  • Esther Moon, PharmD, BCPP

    Pharmacy School: University of California, San Francisco

    PGY1: Dignity Health – Saint Joseph's Medical Center

    PGY2: Psychiatric Pharmacy – Riverside University Health System

  • Sabrina Domicoli Snyder, PharmD, BCPP

    Pharmacy School: University of Southern California

    PGY1: Riverside University Health System

    PGY2: Psychiatric Pharmacy – Riverside University Health System

  • Susie Park, PharmD, APh, BCPP, FCSHP

    Pharmacy School: University of Southern California

    PGY1: University of Southern California

Select Publications Related to a PGY1 Pharmacy Research Project

View research publications
  1. Kapustova K, Phan B, Allison-Aipa T, Choi M. Acute rate control with metoprolol versus diltiazem in atrial fibrillation with heart failure with reduced ejection fraction. Am J Emerg Med. 2023;67:126-129.
  2. Moon E, Kim E, Williams AM. Initiation of Aripiprazole Lauroxil Long-Acting Injectable in Adolescents During Hospitalization: A Case Series. J Child Adolesc Psychopharmacol. 2023 Dec;33(10):433-438.
  3. Nguyen A, Chang J, Allison-Aipa T, Albini P. A Comparison of Monotherapy and Combination Therapy With Antipsychotic Medications for Intensive Care Unit Delirium: A Retrospective Cohort Study. Annals of Pharmacotherapy. 2025;0(0).
  4. Snyder SD, Williams AM, Mitchell M, Kneebusch J. Use of Intramuscular Chlorpromazine versus Intramuscular Olanzapine for the Management of Acute Agitation and Aggression in Youth. J Pediatr Pharmacol Ther. 2021;26(1):33-41.
  5. Williams AM, Mong R, Chijiwa K, et al. Use of intramuscular midazolam, diphenhydramine, and haloperidol in acute agitation management in a psychiatric emergency department. Journal of Clinical Psychopharmacology. June 2025. doi:10.1097/jcp.0000000000002027.

Educational Resources

Residents are required to attend the following educational conferences:

  • ASHP Midyear Clinical Meeting and Exhibition
  • Western States Conference for Pharmacy Residents, Fellows and Preceptors
Group of doctors

A total of 10 days are built into residents' schedules for required conferences. Residents will attend the required conferences in their entirety unless specified otherwise by the Residency Program Director (RPD). Residents are expected to attend the presentations of all other RUHS pharmacy residents at the Western States Conference. Travel and registration are reimbursed for required meeting attendance. Residents may request leave for additional educational meetings up to one week in duration. Travel is not reimbursed for additional educational meetings. Requests must be submitted 4 weeks in advance, and approval is granted solely at the discretion of the RPD.

Prospective Residents

Position Title: PGY-1 Pharmacy Resident (12-Month Trainee Appointment)

Total Number of Positions: 4

How to Apply

  • ASHP Program Code #92117
  • Submit application through PhORCAS
  • Application due date: January 3
  • Register with ASHP Resident Matching Program
  • National Matching Services Code #235613
  • Onsite interview

Application Materials Must Include

  • Official transcript from the School of Pharmacy
  • Three letters of recommendation
  • Letter of intent that specifies your interests and goals
  • Curriculum Vitae

Applicant Requirements

An applicant for the Pharmacy Residency Program must:

  • Have received or be a candidate of a Doctor of Pharmacy degree from an ACPE-accredited School of Pharmacy, or have a Foreign Pharmacy Graduate Equivalency Committee (FPGEC) certificate from the National Association of Boards of Pharmacy (NABP)
  • Be licensed or eligible for licensure in the State of California
  • Be a citizen of the U.S.A. or hold a visa allowing for completion of the residency year
  • Submit application materials through PhORCAS
  • Adhere to the rules of the ASHP Pharmacy Resident Matching Program (RMP)
  • Be a highly motivated individual who desires advanced training and an enhanced level of professional competence in pharmacy practice
  • Visa sponsorship is not available

Application Process

Applications must be received by the designated PhORCAS deadline to be considered for the residency program. Residents for the PGY1 program are selected through the matching program.

After applications have been reviewed by the Residency Program Director and the Selection Committee (members of the Residency Advisory Committee) through a set of predetermined selection criteria, qualified applicants will be invited for an on-site interview at their own expense.

Selection Criteria

Criteria for selection to the RUHS PGY1 Pharmacy Practice Residency include:

  • Communication skills, maturity, and self-confidence
  • Leadership, awareness, and time management
  • Motivation, professional interest, and integrity
  • Knowledge base
  • Critical thinking and clinical reasoning
  • Scholastic achievements
  • Work experiences

These criteria will be evaluated through applicants' CVs, interviews, references, school transcripts, and recommendation letters. The interview panel will reconvene upon completion of the interview process to discuss and review feedback from interview scores and rank prospective candidates based on these predetermined criteria. Final ranking will be submitted to the ASHP Resident Matching Program.

Phase II Match and Scramble shall follow the same selection process with a condensed virtual interview.